HOMCY CHARLES J - Insider Non-Derivative Transactions at BridgeBio Pharma, Inc. (BBIO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 16, 2024, HOMCY CHARLES J's relationship to BridgeBio Pharma, Inc. (BBIO) is Director, and currently has 1,231,594 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other BBIO insiders.
Data Source: SEC.
HOMCY CHARLES J - Insider Non-Derivative Transactions of BBIO Common Stock
HOMCY CHARLES J - Insider Non-Derivative Transactions at BBIO
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Feb 17, 2024 | F -- (Common Stock) | 1509 | 37.21 | 1230085 |
Feb 17, 2024 | M -- (Common Stock) | 3760 | 0 | 1231594 |
Nov 17, 2023 | F -- (Common Stock) | 1301 | 28.86 | 1226996 |
Nov 17, 2023 | M -- (Common Stock) | 3760 | 0 | 1228297 |
Aug 17, 2023 | F -- (Common Stock) | 1301 | 29.8 | 1224537 |
Aug 17, 2023 | M -- (Common Stock) | 3760 | 0 | 1225838 |
May 17, 2023 | F -- (Common Stock) | 1300 | 14.09 | 1220827 |
May 17, 2023 | M -- (Common Stock) | 3759 | 0 | 1222127 |
Feb 17, 2023 | F -- (Common Stock) | 1534 | 12.64 | 1218368 |
Feb 17, 2023 | M -- (Common Stock) | 3760 | 0 | 1219902 |